Rakuten Investment Management Inc. Invests $566,000 in Kenvue Inc. $KVUE

Rakuten Investment Management Inc. acquired a new position in shares of Kenvue Inc. (NYSE:KVUEFree Report) in the third quarter, Holdings Channel reports. The institutional investor acquired 34,850 shares of the company’s stock, valued at approximately $566,000.

A number of other large investors also recently bought and sold shares of the stock. Salomon & Ludwin LLC purchased a new position in Kenvue during the third quarter worth about $25,000. NBT Bank N A NY lifted its holdings in shares of Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after acquiring an additional 1,006 shares during the last quarter. Trust Co. of Vermont lifted its holdings in shares of Kenvue by 266.8% in the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after acquiring an additional 1,150 shares during the last quarter. New England Capital Financial Advisors LLC boosted its position in shares of Kenvue by 81.4% during the 3rd quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock worth $42,000 after purchasing an additional 1,150 shares during the period. Finally, Future Financial Wealth Managment LLC acquired a new stake in Kenvue in the 3rd quarter valued at approximately $49,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Edward Jones lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. UBS Group cut their price objective on Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Evercore ISI set a $18.00 target price on Kenvue in a research note on Tuesday, October 28th. Citigroup dropped their target price on Kenvue from $20.00 to $17.00 and set a “neutral” rating for the company in a research report on Thursday, October 9th. Finally, Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.23.

Check Out Our Latest Report on KVUE

Insider Activity at Kenvue

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were purchased at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the acquisition, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This represents a 13.27% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.68% of the company’s stock.

Kenvue Stock Performance

Shares of Kenvue stock opened at $17.82 on Friday. The business has a 50-day simple moving average of $17.05 and a 200-day simple moving average of $18.15. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The company has a market cap of $34.14 billion, a PE ratio of 23.76 and a beta of 0.60.

Kenvue (NYSE:KVUEGet Free Report) last issued its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The firm had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. During the same quarter last year, the company earned $0.28 earnings per share. The firm’s revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend was Wednesday, November 12th. Kenvue’s payout ratio is 110.67%.

About Kenvue

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Recommended Stories

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUEFree Report).

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.